Philippines

Resilience System

Main menu


You are here

Home › New studies indicate Paxlovid does not relieve long COVID symptoms im adults or prevent condition in teenagers › New studies indicate Paxlovid does not relieve long COVID symptoms im adults or prevent condition in teenagers

New studies indicate Paxlovid does not relieve long COVID symptoms im adults or prevent condition in teenagers

Primary tabs

New studies indicate Paxlovid does not relieve long COVID symptoms im adults or prevent condition in teenagers

Thu, 2025-04-10 00:00 — mike kraft
Reports: Paxlovid doesn't relieve adult long-COVID symptoms, prevent condition in youth Tomorrow, pharmaceuticals will no longer be exempt from the Trump administration's 25% tariff on goods produced in Canada. CIDRAP

A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the symptoms of adult long-COVID patients or in preventing the development of the condition in adolescents.

..

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Symptoms
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.383 seconds.